Serious adverse events · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell showed no clear difference in serious Adverse Events compared with placebo or Control (low certainty).
1 finding from 1 review
Adverse events · mainly physically active individuals1 partaking in exercise2 designed to produce delayed onset muscle soreness
1 finding from 1 review
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage
It is very uncertain whether summary of findings table ‐ Recombinant activated factor VII changes all serious adverse events compared with placebo/open control (very low certainty).
1 finding from 1 review
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Adverse events · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes withdrawal due to adverse events compared with placebo or Control (very low certainty).
1 finding from 1 review
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Adverse eventsf · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Serious adverse events (6 months · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Adverse events · physically‐active adults partaking in exercise designed to produce delayed onset muscle soreness (most trial participants were male)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Adverse events · Older people living in the community (trials focusing on people recently discharged from hospital were not included)
1 finding from 1 review
Adverse eventsd · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Number of any adverse events: immediately after treatment · overactive bladder
1 finding from 1 review
Adverse events ‐ total participants with adverse events · patients (mainly young male adults) with fractures of the middle third of the clavicle
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of any adverse events: immediately after treatment · overactive bladder
It is very uncertain whether summary of findings table ‐ Bladder training changes number of any adverse events: immediately after treatment compared with anticholinergics (very low certainty).
1 finding from 1 review
Number of any adverse events: immediately after treatment · overactive bladder
1 finding from 1 review
Frequency of adverse events ( · Children undergoing stem cell transplant with malignant and non‐malignant diseases and risk factors for hepatic veno‐occlusive disease
It is very uncertain whether summary of findings: Defibrotide changes frequency of adverse events ( compared with no treatment (very low certainty).
1 finding from 1 review